Abstract:Objective: To summarize the clinical and genetic characteristics of mental retardation disorder (MRD) with TRIO gene variant in children. Methods: Case series study. The data of 9 children with TRIO gene variants were collected retrospectively from August 2019 to March 2024 in Department of Neurology, Beijing Children's Hospital, Capital Medical University and Department of Pediatrics, the Third Affiliated Hospital of Zhengzhou University. The data included gender, age, intellectual and motor development, appearance, seizures, neuroimaging and genetic results. The clinical features and genotype-phenotype correlations were summarized. Results: Of the 9 children, 6 boys and 3 girls, 4 MRD63 children presented with moderate to severe developmental delays accompanied by macrocephaly; 5 MRD44 children had mild to moderate developmental delays with microcephaly. A total of 5 children had dysmorphic facial features (flat occiput, thick eyebrows, unibrow, large ears, short fingers, pale skin, yellow hair, and strabismus), 2 children experienced seizures (1 child with myoclonic seizure and 1 with absence seizure), 4 children had feeding difficulties, 1 child had congenital cataracts, 1 child had congenital heart disease, 1 child had recurrent infections, and 1 child had tiger-striped changes in the fundus examination. TRIO gene variants carried by the 9 children were all de novo, involving 8 variant sites, including 7 missense variants and 1 frameshift variant, c.3232C>T/p.R1078W (2 cases), c.3920A>G/p.Y1307C, c.4112A>T/p.H1371L, c.4283G>T/p.R1428L, c.4394A>G/p.N1465S, c.6041T>C/p.I2014T, c.6821G>A/p.R2274H, c.7027delC/p.Q2343Sfs*70. Among them, 2 sites are located in the Spectrin domain, 4 sites are in the GEFD1 domain, 2 sites are in the GEFD2 domain, and 1 site (frameshift variant) is in the PH2-SH3 domain. The individual with frameshift variant exhibit absence seizures, mild developmental delay, and the mildest phenotype. The child with myoclonic seizures was treated with valproic acid and levetiracetam for seizure control, while the child with absence epilepsy was treated with valproic acid and lamotrigine for seizure control. All 9 children underwent regular rehabilitation exercises, making slow progress. Conclusions: TRIO gene related MRD is characterized by varying degrees of developmental delay, and often accompanied by macrocephaly or microcephaly, dysmorphic facial features, and with or without seizures. The main variant types are missense variants, which are mostly concentrated in the Spectran domain and GEFD domain. p. R1078W may be a relative hotspot variant. The phenotype caused by the frameshift variant is relatively milder.

Neurodevelopmental Disease-Associated De Novo Mutations and Rare Sequence Variants Affect TRIO GDP/GTP Exchange Factor Activity.

Heterozygosity for neurodevelopmental disorder-associated TRIO variants yields distinct deficits in behavior, neuronal development, and synaptic transmission in mice

Trio Haploinsufficiency Causes Neurodevelopmental Disease-Associated Deficits.

Both GEF domains of the autism and developmental epileptic encephalopathy-associated Trio protein are required for proper tangential migration of GABAergic interneurons

An autism spectrum disorder-related de novo mutation hotspot discovered in the GEF1 domain of Trio

Extending the phenotypes associated with TRIO gene variants in a cohort of 25 patients and review of the literature

RhoGEF Trio Regulates Radial Migration of Projection Neurons via Its Distinct Domains

Detection of autism spectrum disorder-related pathogenic trio variants by a novel structure-based approach

Dysfunction of Trio GEF1 involves in excitatory/inhibitory imbalance and autism-like behaviors through regulation of interneuron migration

RNA analysis and computer‐aided facial phenotyping help to classify a novel TRIO splice site variant

Distinct Functions of Trio GEF Domains in Axon Outgrowth of Cerebellar Granule Neurons

Case report: Phenotype expansion and analysis of TRIO and CNKSR2 variations

[Clinical characteristics and genetic analysis of mental retardation disorder with TRIO gene variant]

Trio is a Key Guanine Nucleotide Exchange Factor Coordinating Regulation of the Migration and Morphogenesis of Granule Cells in the Developing Cerebellum

Molecular dynamics simulation of RAC1 protein and its de novo variants related to developmental disorders

The Role of Microtubule Associated Serine/Threonine Kinase 3 Variants in Neurodevelopmental Diseases: Genotype-Phenotype Association

Golgi-resident TRIO Regulates Membrane Trafficking During Neurite Outgrowth

The Role of <i>Microtubule Associated Serine/Threonine Kinase 3</i> Variants in Neurodevelopmental Diseases: Genotype-Phenotype Association

Variants in RHOBTB2 associated with cancer and rare developmental and epileptic encephalopathy

Patient mutations in DRP1 perturb synaptic maturation of cortical neurons

Dentate Gyrus Morphogenesis is Regulated by an Autism Risk Gene Trio Function in Granule Cells